Lupin Ltd (LUPIN) — share price & stock analysis
From losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days.
Lupin Ltd (LUPIN) trades at ₹2,398 as of 1 July 2026, up 21% over the past year — beating NIFTY 500 for 31 weeks. The machine reads this as turnaround, cheap vs history: from losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days. It trades at a P/E of 19.0× (the lowest of its own range); the price is in Stage 2 — advancing, 30 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 93/100 (mostly improving).
Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.
- Market cap
- ₹1,09,622 Cr
- P/E
- 19×
- ROE
- 29.1%
- vs own 10-yr valuation
- lowest ever
- Book value / share
- ₹491
- EPS (TTM)
- ₹126
- 10-yr median P/E
- 28.8×
- Revenue (FY26)
- ₹27,958 Cr
- Profit after tax (FY26)
- ₹5,355 Cr
- Weinstein stage
- Stage 2 (30 weeks)
- Data as of
- 1 July 2026
Profits swing violently in this business — real losses in FY20 and FY22. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit
Where the clock stands now: earnings sit at 100% of their historical range, margins are the best ever printed, and the market pays the cheap end of its range (0th percentile). That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit
One tension to hold: the margins are the best this company has ever printed while the market still prices the stock at the cheap end of its own history. Either the market is late — or it remembers how cycles in this industry end. That disagreement is the actual bet.
5 of the 6 things we track are currently moving the right way — nearly everything is pulling in the same direction.
Where the levels actually stand: ROCE 30% — a high-quality engine; effectively no debt; margins at an all-time high. Momentum says which way things are moving; these say where they are.
Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).
Earnings moved first — the price is still catching up
Since Mar 2016, earnings per share grew 151% while the stock is up 64%. The business has outrun its own share price.pricettm_eps
When profits grow faster than the price, the stock quietly gets cheaper while doing better — the market hasn’t fully caught up.
Today’s P/E of 19× is about the cheapest this stock has ever traded against its own 10-year history.pe_ratio
One caveat: this history includes FY20 and FY22, when earnings collapsed and the P/E was sky-high. “Cheapest ever” partly reflects earnings finally normalising, not just a cheap price.net_profit
And the sharper caveat: today’s margins are the best this company has ever printed. The cheap multiple is only real if they hold — earnings at record profitability flatter every valuation ratio.operating_profit
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
| Period | Price (₹) | EPS (TTM) (₹) | P/E (×) |
|---|---|---|---|
| Mar 16 | 1,524 | – | 33.3 |
| Jun 16 | 1,450 | 50.2 | 28.9 |
| Aug 16 | 1,582 | 57.1 | 27.7 |
| Oct 16 | 1,500 | 62.5 | 24.0 |
| Dec 16 | 1,487 | 64.9 | 23.8 |
| Mar 17 | 1,447 | 64.9 | 22.3 |
| May 17 | 1,318 | 64.9 | 20.3 |
| Jul 17 | 1,064 | 45.1 | 23.6 |
| Oct 17 | 1,039 | 45.0 | 23.1 |
| Dec 17 | 860 | 40.4 | 21.3 |
| Feb 18 | 808 | 31.3 | 25.8 |
| May 18 | 796 | 31.3 | 25.4 |
| Jul 18 | 866 | 6.2 | 139.4 |
| Sep 18 | 890 | 31.5 | 28.3 |
| Nov 18 | 887 | – | 32.6 |
| Feb 19 | 831 | 4.3 | 191.4 |
| Apr 19 | 836 | – | 192.6 |
| Jun 19 | 755 | – | – |
| Sep 19 | 773 | – | – |
| Nov 19 | 742 | – | – |
| Jan 20 | 740 | – | – |
| Apr 20 | 656 | – | – |
| Jun 20 | 912 | – | – |
| Aug 20 | 981 | – | – |
| Oct 20 | 909 | – | – |
| Jan 21 | 1,039 | – | – |
| Mar 21 | 1,005 | 23.8 | 42.2 |
| May 21 | 1,209 | 26.8 | 45.1 |
| Aug 21 | 1,151 | – | 44.4 |
| Oct 21 | 947 | – | 26.0 |
| Dec 21 | 898 | – | – |
| Mar 22 | 704 | – | – |
| May 22 | 696 | – | – |
| Jul 22 | 640 | – | – |
| Sep 22 | 680 | – | – |
| Dec 22 | 752 | – | – |
| Feb 23 | 670 | – | – |
| Apr 23 | 710 | – | – |
| Jul 23 | 901 | 9.5 | 95.3 |
| Sep 23 | 1,151 | 21.4 | 53.9 |
| Nov 23 | 1,243 | 29.3 | 42.5 |
| Feb 24 | 1,503 | – | 51.4 |
| Apr 24 | 1,622 | 39.4 | 41.2 |
| Jun 24 | 1,561 | 42.1 | 37.1 |
| Aug 24 | 2,240 | 49.7 | 45.1 |
| Nov 24 | 2,105 | 57.6 | 36.5 |
| Jan 25 | 2,113 | 57.6 | 36.7 |
| Mar 25 | 2,028 | 63.0 | 32.2 |
| Jun 25 | 2,000 | 71.9 | 27.8 |
| Aug 25 | 1,962 | 81.1 | 24.2 |
| Oct 25 | 1,931 | 81.1 | 23.8 |
| Jan 26 | 2,105 | 94.8 | 22.2 |
| Mar 26 | 2,344 | 109.0 | 21.5 |
| Apr 26 | 2,305 | 108.7 | 21.2 |
| Jun 26 | 2,272 | 126.2 | 18.0 |
| Jul 26 | 2,398 | 126.2 | 19.0 |
Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots; between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (28.8×).
An uptrend that has held for 30 weeks
STAGE 2 · ADVANCING · 30 WEEKSEvery stock cycles through the same four seasons — a flat base (stage 1), an advance (2), a top (3), a decline (4). Right now this one is in Stage 2: advancing, 30 weeks in, confirmed.stage
The price sits above its rising 200-day average (₹2,200 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200
Beating NIFTY 500 for 31 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield
What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
| Period | Price (₹) | 200-DMA (₹) | 50-DMA (₹) | Stage |
|---|---|---|---|---|
| Feb 16 | 1,727 | 1,772 | 1,770 | 4 |
| May 16 | 1,505 | 1,701 | 1,611 | 4 |
| Aug 16 | 1,582 | 1,647 | 1,616 | 4 |
| Nov 16 | 1,421 | 1,590 | 1,515 | 4 |
| Jan 17 | 1,492 | 1,543 | 1,490 | 4 |
| Apr 17 | 1,408 | 1,504 | 1,450 | 4 |
| Jul 17 | 1,139 | 1,359 | 1,172 | 4 |
| Oct 17 | 1,039 | 1,208 | 1,023 | 4 |
| Dec 17 | 885 | 1,072 | 888 | 4 |
| Mar 18 | 735 | 968 | 817 | 4 |
| Jun 18 | 913 | 889 | 795 | 4 |
| Sep 18 | 959 | 883 | 871 | 4 |
| Nov 18 | 887 | 878 | 866 | 4 |
| Feb 19 | 778 | 859 | 830 | 4 |
| May 19 | 753 | 836 | 815 | 4 |
| Aug 19 | 759 | 798 | 760 | 4 |
| Nov 19 | 766 | 771 | 735 | 4 |
| Jan 20 | 740 | 766 | 756 | 1 |
| Apr 20 | 822 | 728 | 685 | 4 |
| Jul 20 | 861 | 796 | 872 | 2 |
| Oct 20 | 1,028 | 868 | 968 | 2 |
| Dec 20 | 976 | 902 | 943 | 2 |
| Mar 21 | 1,005 | 964 | 1,031 | 2 |
| Jun 21 | 1,230 | 1,038 | 1,157 | 2 |
| Sep 21 | 970 | 1,058 | 1,056 | 2 |
| Nov 21 | 915 | 1,006 | 942 | 4 |
| Feb 22 | 768 | 952 | 874 | 4 |
| May 22 | 696 | 866 | 758 | 4 |
| Aug 22 | 668 | 760 | 646 | 4 |
| Oct 22 | 696 | 725 | 678 | 4 |
| Jan 23 | 755 | 733 | 740 | 2 |
| Apr 23 | 671 | 710 | 676 | 4 |
| Jul 23 | 901 | 750 | 816 | 2 |
| Sep 23 | 1,171 | 891 | 1,071 | 2 |
| Dec 23 | 1,265 | 1,029 | 1,210 | 2 |
| Mar 24 | 1,637 | 1,252 | 1,546 | 2 |
| Jun 24 | 1,630 | 1,407 | 1,611 | 2 |
| Aug 24 | 2,240 | 1,613 | 1,936 | 2 |
| Nov 24 | 2,071 | 1,855 | 2,122 | 2 |
| Feb 25 | 1,970 | 1,983 | 2,128 | 2 |
| May 25 | 2,037 | 1,996 | 2,038 | 3 |
| Aug 25 | 1,867 | 1,980 | 1,956 | 4 |
| Oct 25 | 1,931 | 1,969 | 1,956 | 1 |
| Jan 26 | 2,178 | 2,018 | 2,094 | 2 |
| Apr 26 | 2,334 | 2,122 | 2,263 | 2 |
| Jun 26 | 2,293 | 2,181 | 2,281 | 2 |
| Jul 26 | 2,398 | 2,200 | 2,308 | 2 |
A business that went through the fire — losses in FY20 and FY22, records now
Over 12 years, sales went from ₹11,286 Cr to ₹27,958 Cr (about 8% a year), and profit from ₹1,870 Cr to ₹5,355 Cr.revenuenet_profit
The books show real losses in FY20 and FY22 (worst: ₹−1,528 Cr). Everything about today’s cheap-looking numbers must be read against that history — the recovery is what you are buying.net_profit
Data: Revenue by year
| Period | Revenue (₹ Cr) |
|---|---|
| FY14 | 11,286 |
| FY15 | 12,770 |
| FY16 | 14,256 |
| FY17 | 17,367 |
| FY18 | 15,797 |
| FY19 | 14,665 |
| FY20 | 15,375 |
| FY21 | 15,163 |
| FY22 | 16,405 |
| FY23 | 16,642 |
| FY24 | 20,011 |
| FY25 | 22,708 |
| FY26 | 27,958 |
Data: Profit by year
| Period | Profit after tax (₹ Cr) |
|---|---|
| FY14 | 1,870 |
| FY15 | 2,444 |
| FY16 | 2,270 |
| FY17 | 2,565 |
| FY18 | 258 |
| FY19 | 615 |
| FY20 | -270 |
| FY21 | 1,228 |
| FY22 | -1,528 |
| FY23 | 448 |
| FY24 | 1,936 |
| FY25 | 3,306 |
| FY26 | 5,355 |
Data: OPM % by year
| Period | OPM % (%) |
|---|---|
| FY14 | 26.7 |
| FY15 | 28.4 |
| FY16 | 25.9 |
| FY17 | 25.9 |
| FY18 | 19.9 |
| FY19 | 17.5 |
| FY20 | 15.3 |
| FY21 | 16.9 |
| FY22 | 1.3 |
| FY23 | 10.3 |
| FY24 | 19.0 |
| FY25 | 23.2 |
| FY26 | 31.5 |
Sales jumped 32% last quarter — growth every single quarter for over 2 years
Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year.revenue
That makes 11 quarters of growth in a row — this is a trend, not a blip.revenue
Data: Quarterly sales
| Period | Revenue (₹ Cr) | YoY growth (%) |
|---|---|---|
| Jun 23 | 4,814 | – |
| Sep 23 | 5,039 | – |
| Dec 23 | 5,197 | – |
| Mar 24 | 4,961 | – |
| Jun 24 | 5,600 | 16.3 |
| Sep 24 | 5,673 | 12.6 |
| Dec 24 | 5,768 | 11.0 |
| Mar 25 | 5,667 | 14.2 |
| Jun 25 | 6,268 | 11.9 |
| Sep 25 | 7,048 | 24.2 |
| Dec 25 | 7,168 | 24.3 |
| Mar 26 | 7,475 | 31.9 |
Margins are widening — 23% → 33% in a year
Of every ₹100 of sales, the company keeps ₹33.3 as operating profit (a year ago it kept ₹23.3).opm_pct
Zoom out and this is the page's quiet hero: annual operating margin bottomed at 1.3% in FY22 and has been rebuilt to 31.5% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit
The gross margin moved the same way (70% → 75%), so this is about input costs and pricing power — the raw-material equation improved.gpm_pctopm_pct
Data: Three margins, quarterly
| Period | Gross (%) | Operating (%) | Net (%) |
|---|---|---|---|
| Jun 23 | 65.9 | 17.8 | 9.4 |
| Sep 23 | 66.2 | 18.2 | 9.8 |
| Dec 23 | 66.8 | 20.0 | 11.9 |
| Mar 24 | 68.3 | 20.1 | 7.4 |
| Jun 24 | 68.9 | 22.2 | 14.4 |
| Sep 24 | 70.2 | 23.6 | 15.2 |
| Dec 24 | 70.2 | 23.5 | 14.9 |
| Mar 25 | 70.3 | 23.3 | 13.8 |
| Jun 25 | 71.7 | 27.6 | 19.5 |
| Sep 25 | 74.1 | 33.2 | 21.1 |
| Dec 25 | 73.8 | 31.6 | 21.1 |
| Mar 26 | 75.2 | 33.3 | 20.9 |
Profit exploded 88% — mostly from keeping more of each sale
Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year.net_profit
Data: Quarterly profit after tax
| Period | PAT (₹ Cr) | YoY growth (%) |
|---|---|---|
| Jun 23 | 453 | – |
| Sep 23 | 495 | – |
| Dec 23 | 619 | – |
| Mar 24 | 368 | – |
| Jun 24 | 806 | 77.9 |
| Sep 24 | 859 | 73.5 |
| Dec 24 | 859 | 38.8 |
| Mar 25 | 782 | 112.5 |
| Jun 25 | 1,221 | 51.5 |
| Sep 25 | 1,485 | 72.9 |
| Dec 25 | 1,181 | 37.5 |
| Mar 26 | 1,469 | 87.9 |
The single biggest driver was keeping more of each sale.
Data: Where the profit change came from (Mar 25 → Mar 26)
| Component | Effect (₹ Cr) |
|---|---|
| PAT Mar 25 | 782 |
| More sales | +422 |
| Fatter margins | +744 |
| Other income | −48 |
| Depreciation | −54 |
| Interest | −31 |
| Tax | −345 |
| PAT Mar 26 | 1,469 |
The profits are real — they turn into cash
Over the last 4 profitable years, the business reported ₹11,045 Cr of profit and collected ₹15,879 Cr of operating cash — about 144% conversion (1 loss year excluded — a negative denominator would flatter the ratio).operating_cash_flownet_profit
One asterisk on that strength: suppliers are being paid 50 days later than a year ago (158 → 208 days). Cash flattered by stretching payables is real cash — but it is borrowed timing, not extra earning power.payable_days
Data: Cash collected vs profit reported (annual)
| Period | Operating cash flow (₹ Cr) | Profit after tax (₹ Cr) |
|---|---|---|
| FY14 | 2,004 | 1,870 |
| FY15 | 2,733 | 2,444 |
| FY16 | -382 | 2,270 |
| FY17 | 4,114 | 2,565 |
| FY18 | 1,751 | 258 |
| FY19 | 1,666 | 615 |
| FY20 | 1,469 | -270 |
| FY21 | 1,822 | 1,228 |
| FY22 | 367 | -1,528 |
| FY23 | 1,897 | 448 |
| FY24 | 3,648 | 1,936 |
| FY25 | 3,000 | 3,306 |
| FY26 | 7,334 | 5,355 |
The cash cycle looks tighter — but it is supplier credit doing the work
One rupee now takes about 181 days to go out the door as materials and come back as collected cash — down from 223 days the year before.cash_conversion_cycle
Look inside the improvement, though: suppliers are being paid 50 days later (158 → 208 days), while inventory actually got heavier (292 → 303 days). Supplier credit is funding the cycle — useful, but not the same thing as customers paying faster.payable_daysinventory_days
Data: Days of cash locked up (annual)
| Period | Customers owe (debtor days) (days) | Stock on shelf (inventory days) (days) | We owe suppliers (payable days) (days) |
|---|---|---|---|
| FY14 | 80.0 | 204 | 152 |
| FY15 | 76.0 | 220 | 172 |
| FY16 | 116 | 276 | 168 |
| FY17 | 91.0 | 266 | 189 |
| FY18 | 120 | 253 | 178 |
| FY19 | 128 | 283 | 184 |
| FY20 | 129 | 232 | 162 |
| FY21 | 108 | 279 | 137 |
| FY22 | 95.0 | 261 | 129 |
| FY23 | 98.0 | 242 | 136 |
| FY24 | 86.0 | 272 | 163 |
| FY25 | 88.0 | 292 | 158 |
| FY26 | 86.0 | 303 | 208 |
The asset base keeps compounding — this company builds
The productive asset base has gone from ₹3,356 Cr (FY14) to ₹11,315 Cr, with another ₹695 Cr of capacity under construction right now.fixed_assetscwip
The build is self-funded: the last 3 years' investing outflow (₹9,749 Cr) fits inside the operating cash the business generated (₹13,982 Cr).investing_cash_flowoperating_cash_flow
Data: Assets in place vs under construction (annual)
| Period | Fixed assets (₹ Cr) | Under construction (CWIP) (₹ Cr) |
|---|---|---|
| FY14 | 3,356 | 304 |
| FY15 | 4,368 | 576 |
| FY16 | 8,717 | 2,702 |
| FY17 | 11,033 | 2,133 |
| FY18 | 10,362 | 2,598 |
| FY19 | 11,087 | 1,640 |
| FY20 | 7,938 | 940 |
| FY21 | 7,881 | 1,066 |
| FY22 | 7,382 | 1,146 |
| FY23 | 8,355 | 1,238 |
| FY24 | 8,878 | 773 |
| FY25 | 9,719 | 517 |
| FY26 | 11,315 | 695 |
Debt is small — but no longer zero, and growing
For every ₹100 shareholders have put in (and left in), the company has borrowed ₹29 — total borrowings have grown from ₹654 Cr to ₹6,616 Cr over the window.borrowings
The equity base grew even faster, so the ratio stays comfortable — but a 10× rise in absolute borrowings deserves a name (acquisitions, capex), not a shrug. Watch whether it keeps compounding.borrowings
Data: Total borrowings (annual)
| Period | Borrowings (₹ Cr) |
|---|---|
| FY14 | 654 |
| FY15 | 537 |
| FY16 | 7,178 |
| FY17 | 7,966 |
| FY18 | 7,143 |
| FY19 | 8,496 |
| FY20 | 6,305 |
| FY21 | 4,783 |
| FY22 | 4,158 |
| FY23 | 4,542 |
| FY24 | 2,922 |
| FY25 | 5,448 |
| FY26 | 6,616 |
Data: Debt vs shareholders’ money (annual)
| Period | Debt ÷ equity (x) |
|---|---|
| FY14 | 0.1 |
| FY15 | 0.1 |
| FY16 | 0.6 |
| FY17 | 0.6 |
| FY18 | 0.5 |
| FY19 | 0.6 |
| FY20 | 0.5 |
| FY21 | 0.4 |
| FY22 | 0.3 |
| FY23 | 0.4 |
| FY24 | 0.2 |
| FY25 | 0.3 |
| FY26 | 0.3 |
Every ₹100 kept in the business now earns ₹30 — and the number is rising
Return on capital employed is 30.0% (a year ago: 21.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct
Rising returns on capital while growing is the rarest combination in investing — it means the new projects earn more than the old ones.roce_pct
Data: Returns on capital (annual)
| Period | ROCE (%) |
|---|---|
| FY14 | 41.0 |
| FY15 | 40.0 |
| FY16 | 24.0 |
| FY17 | 19.0 |
| FY18 | 10.0 |
| FY19 | 10.0 |
| FY20 | 9.0 |
| FY21 | 9.0 |
| FY22 | -7.0 |
| FY23 | 6.0 |
| FY24 | 16.0 |
| FY25 | 21.0 |
| FY26 | 30.0 |
The owners aren’t moving
Promoters hold 46.9%, essentially unchanged. Foreign funds own 21.7%, domestic funds 25.3%.promoters_pctfiis_pctdiis_pct
Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t.
Meanwhile domestic funds have been the sellers — from 29.1% to 25.3% over the window. Someone on the other side of the table disagrees; both sides count.diis_pct
Data: Who holds the shares, quarterly
| Period | Promoters (%) | Foreign funds (%) | Domestic funds (%) |
|---|---|---|---|
| Jun 23 | 47.1 | 13.9 | 29.1 |
| Sep 23 | 47.1 | 15.0 | 29.1 |
| Dec 23 | 47.0 | 16.1 | 29.7 |
| Mar 24 | 47.0 | 18.3 | 27.8 |
| Jun 24 | 47.0 | 19.3 | 26.8 |
| Sep 24 | 47.0 | 21.5 | 25.1 |
| Dec 24 | 46.9 | 22.0 | 24.7 |
| Mar 25 | 46.9 | 21.5 | 25.4 |
| Jun 25 | 46.9 | 21.3 | 25.6 |
| Sep 25 | 46.9 | 20.5 | 26.6 |
| Dec 25 | 46.9 | 21.5 | 25.6 |
| Mar 26 | 46.9 | 21.7 | 25.3 |
- Promoters are not selling. Their stake has moved 0.1 points or less in 8 quarters — it sits at 46.9%.promoters_pct
The numbers earn a deeper study — and watch the one thing that matters
The numbers lean positive, and the price hasn’t fully caught up with the improvement.
Best thing in the data: free cash flow rising (₹−1,172 Cr → ₹3,469 Cr).operating_cash_flow
Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.
Straight answers from the data
What does Lupin Ltd do?
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. It is listed in the Pharma - Formulators sector with a market capitalisation of ₹1,09,622 Cr.
What is Lupin Ltd's share price?
As of 1 July 2026, Lupin Ltd trades at ₹2,398, up 21% over the past year, with a market capitalisation of ₹1,09,622 Cr. Beating NIFTY 500 for 31 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.
What is Lupin Ltd's share price target?
Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Lupin Ltd's intrinsic value at ₹6,414 per share under base assumptions (bear ₹2,012, bull ₹6,414), against the current price of ₹2,398 — a 174% margin of safety. The current price already implies roughly 11% annual earnings growth. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.
Is Lupin Ltd stock overvalued or undervalued?
Lupin Ltd trades at a P/E of 19.0× — the lowest of its own 10.3-year trading range (median 28.8×). Earnings moved first — the price is still catching up. Since Mar 2016, earnings per share grew 151% while the stock is up 64%. The business has outrun its own share price. One caveat: margins are currently above their own all-time band, so the earnings behind that multiple may themselves be at a cyclical high — the stock is cheaper than its history partly because the E is fatter than usual.
What did Lupin Ltd report in its latest quarterly results?
In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year. Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.
Is Lupin Ltd growing?
Sales jumped 32% last quarter — growth every single quarter for over 2 years. Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year.
Are Lupin Ltd's profits growing?
Profit exploded 88% — mostly from keeping more of each sale. Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year.
What are Lupin Ltd's operating margins?
Margins are widening — 23% → 33% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹33.3 as operating profit (a year ago it kept ₹23.3).
What is Lupin Ltd's long-term growth record?
Revenue grew from ₹11,286 Cr in FY14 to ₹27,958 Cr in FY26 — a 7.9% compound annual growth rate over 12 years. Profit after tax compounded at 9.2% over the same period (₹1,870 Cr → ₹5,355 Cr).
Is Lupin Ltd stock in an uptrend?
An uptrend that has held for 30 weeks. Lupin Ltd is in Stage 2 — advancing, 30 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).
Why is Lupin Ltd stock rising?
The price is up 21% over the past year, in a confirmed Stage 2 uptrend (30 weeks), and has beaten NIFTY 500 for 31 weeks. Since 2016, the price is up 64% while earnings per share moved 151%.
Is Lupin Ltd beating the NIFTY 500?
Yes — beating NIFTY 500 for 31 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.
Where is Lupin Ltd in its business cycle?
The data reads Lupin Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company, valuation at its all-time lows. Profits swing violently in this business — real losses in FY20 and FY22. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.
Who owns Lupin Ltd — what is the promoter holding?
Promoters hold 46.9%, essentially unchanged. Foreign funds own 21.7%, domestic funds 25.3%. Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t. Shareholding is from Screener's quarterly filings data.
Does Lupin Ltd have too much debt?
Debt is small — but no longer zero, and growing. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹29 — total borrowings have grown from ₹654 Cr to ₹6,616 Cr over the window.
What is the bull case for Lupin Ltd?
From losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days. Best thing in the data: free cash flow rising (₹−1,172 Cr → ₹3,469 Cr). Sales jumped 32% last quarter — growth every single quarter for over 2 years.
What is the bear case for Lupin Ltd — what could break the story?
Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 16%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.
Is Lupin Ltd a stock worth studying right now?
Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: the numbers earn a deeper study — and watch the one thing that matters. The numbers lean positive, and the price hasn’t fully caught up with the improvement. Across the 7-model scorecard the composite research signal is study deeper at 78% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.